Back to
Citadel Advisors LLC
UTHR
Showing 8 of 31 quarters
Position history for
Citadel Advisors LLC's holdings in United Therapeutics Corporation
Yes. Citadel Advisors holds 928,464 shares of UTHR (United Therapeutics), worth $503.1M, as of its Q3 2026 13F filing. It increased the position from 304,692 shares in Q2 2026. Citadel Advisors has held UTHR since Q4 2024, across 8 quarterly 13F filings. UTHR is 0.1% of Citadel Advisors' reported 13F portfolio.
Current Value
$503.1M
Current Shares
928,464
Total Value Change
+$495.9M
Total Shares Change
+908,126
Quarter-by-Quarter History
Other major holders of UTHR: BlackRock, Inc.